What we’ve been up to

At 3xP Global, we believe that the financial landscape is undergoing a fundamental shift. As the first independent asset management company in Portugal to achieve B Corp certification, our mission is to lead by example. We manage the Impact Innovation Fund (IIF), a €25M vehicle co-financed by the Capitalization and Resilience Fund (FdCR) with a clear mandate: to prove that venture capital / private equity can be a powerful force for social and environmental regeneration in the Iberian Peninsula. Our First Impact Report is our way of documenting this "invisible" value and the path we’ve already traced.

3xP Global is proud to announce the investment in nuAura Health through our Health Innovation Fund. This partnership underscores 3xP Global's commitment to backing transformative technologies that redefine the boundaries of medical care and wellness.

The Portuguese economy is facing a crucial cycle to achieve various strategic objectives. Balancing growth with resilience and security, competitiveness with well-being, and innovation with long-term sustainability are some of the most relevant challenges.

Chrono Health, a pioneering health-tech startup developing an advanced AI-driven system for longitudinal health tracking, is 3xP Global's most recent investment. Channeled through 3xP Global’s Health Innovation Fund, this investment reinforces our commitment to scaling technologies that empower patients and modernize the healthcare landscape.

3xP Global's Impact Innovation Fund (IIF) welcomes Mezze, a pioneering social enterprise born from the visionary work of the Associação Pão a Pão.

3xP Global Impact Innovation Fund will support ECO-ONE’s expansion into Portugal, helping roll out its innovative sustainability model across hotels and tourism operators. Building on its strong presence in Spain and France, this investment will accelerate its growth and strengthen its ability to deliver integrated sustainability solutions in the Portuguese tourism market.

In the spotlight today is Bloodflow, a pioneering company leveraging the power of Artificial Intelligence to revolutionize medical diagnostics.

The new Board has been structured with an executive and non-executive format to consolidate the components of Governance and Operational Organization.

With a distinguished career spanning over 30 years, Raul brings a wealth of diverse experience and a strong record of executive leadership in the financial sector.